GlassScriptPhysician profile
Seth A Courson
NPI 1952763302
$4,009.49
in general payments reported to CMS, 2019-2025
43 companies · $577 in 2025
The $577 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $260 · 2020: $374 · 2021: $600 · 2022: $613 · 2023: $852 · 2024: $733 · 2025: $577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,162.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,162.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $614.54 | 2019-2025 | |
| Dexcom, INC. | $449.53 | 2021-2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $442.51 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Corium, LLC | $180.32 | 2021-2024 | Azstarys |
| Abbott Laboratories | $177.01 | 2021-2025 | Freestyle Libre, Freestyle Libre 2 |
| Lilly USA, LLC | $159.64 | 2020-2025 | Mounjaro, Zepbound, Trulicity |
| Merck Sharp & Dohme LLC | $136.91 | 2022-2024 | Gardasil 9, Vaxneuvance, Gardasil |
| Sanofi-Aventis U.S. LLC | $135.64 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $133.09 | 2022-2025 | |
| Biohaven Pharmaceuticals, INC. | $132.24 | 2021 | |
| Janssen Pharmaceuticals, INC | $129.19 | 2019-2024 | Spravato, Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2023 | Jardiance |
| Ironshore Pharmaceuticals INC. | $122.87 | 2022-2024 | Jornay Pm |
| Astrazeneca Pharmaceuticals LP | $121.70 | 2020-2025 | Airsupra, Flumist Quadrivalent |
| Abbvie INC. | $83.16 | 2021-2025 | Qulipta |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Courson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.